Skip to main content

Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.19
-3.45 (-1.64%)
AAPL  271.82
-2.41 (-0.88%)
AMD  202.41
-8.45 (-4.01%)
BAC  51.92
+0.23 (0.44%)
GOOG  305.36
-7.67 (-2.45%)
META  654.11
+0.42 (0.06%)
MSFT  399.20
-1.40 (-0.35%)
NVDA  185.97
-9.59 (-4.90%)
ORCL  146.59
-1.30 (-0.88%)
TSLA  404.45
-12.95 (-3.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.